Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin J Lastwika

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Biotechnology|December 23, 2023
Breaking tolerance: autoantibodies can target protein posttranslational modificationsKristin J Lastwika, Paul D Lampe
Journal of Cell Science|August 21, 2019
Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repairKristin J Lastwika, Clarence A Dunn, Joell L Solan, et al.
Journal of Proteome Research|October 23, 2016
Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with ObesityCarly B Garrison, Kristin J Lastwika, Yuzheng Zhang, et al.
Genes & Cancer|January 4, 2014
Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf lossGemma L Robinson, James P Robinson, Kristin J Lastwika, et al.
Pigment Cell & Melanoma Research|May 7, 2010
Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox miceMatthew W VanBrocklin, James P Robinson, Kristin J Lastwika, et al.
Neuro-Oncology|October 22, 2011
Ink4a/Arf loss promotes tumor recurrence following Ras inhibitionMatthew W Vanbrocklin, James P Robinson, Kristin J Lastwika, et al.
European Radiology|May 23, 2019
Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control studyWei Wu, Larry A Pierce, Yuzheng Zhang, et al.
Molecular Pharmaceutics|February 8, 2024
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung CancerSamantha M Sarrett, Cindy Rodriguez, Samantha Delaney, et al.
Cancers|July 14, 2023
Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk AssessmentKristin J Lastwika, Wei Wu, Yuzheng Zhang, et al.
Cancer Research|December 6, 2015
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung CancerKristin J Lastwika, Willie Wilson, Qing Kay Li, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Biotechnology|December 23, 2023
Breaking tolerance: autoantibodies can target protein posttranslational modificationsKristin J Lastwika, Paul D Lampe
Journal of Cell Science|August 21, 2019
Phosphorylation of connexin 43 at MAPK, PKC or CK1 sites each distinctly alter the kinetics of epidermal wound repairKristin J Lastwika, Clarence A Dunn, Joell L Solan, et al.
Journal of Proteome Research|October 23, 2016
Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with ObesityCarly B Garrison, Kristin J Lastwika, Yuzheng Zhang, et al.
Genes & Cancer|January 4, 2014
Akt signaling accelerates tumor recurrence following ras inhibition in the context of ink4a/arf lossGemma L Robinson, James P Robinson, Kristin J Lastwika, et al.
Pigment Cell & Melanoma Research|May 7, 2010
Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox miceMatthew W VanBrocklin, James P Robinson, Kristin J Lastwika, et al.
Neuro-Oncology|October 22, 2011
Ink4a/Arf loss promotes tumor recurrence following Ras inhibitionMatthew W Vanbrocklin, James P Robinson, Kristin J Lastwika, et al.
European Radiology|May 23, 2019
Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control studyWei Wu, Larry A Pierce, Yuzheng Zhang, et al.
Molecular Pharmaceutics|February 8, 2024
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung CancerSamantha M Sarrett, Cindy Rodriguez, Samantha Delaney, et al.
Cancers|July 14, 2023
Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk AssessmentKristin J Lastwika, Wei Wu, Yuzheng Zhang, et al.
Cancer Research|December 6, 2015
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung CancerKristin J Lastwika, Willie Wilson, Qing Kay Li, et al.
Pageof 2